Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients
Clinical trial NCT06495281 · COMPLETED
Trial details
- NCT number
- NCT06495281
- Sponsor
- LG Chem
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-26
- Primary completion
- 2025-12-03
- Enrollment
- 2044
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.